TNFAIP6 and intestinal obstruction: After the administration of MSCs, Ad-MSCs, or Tnfaip6, the intestinal obstruction and adhesion of intestinal tissue were significantly improved, no transmural ulcers were observed, glands were more orderly than those in the model group, inflammatory infiltrations were significantly reduced, and inflammation-related histologic score was lower than that of the model group (p < 0.05) (Figures 6A–C).